# DESCRIPTION

## STATEMENT OF FEDERALLY FUNDED RESEARCH

## TECHNICAL FIELD OF THE INVENTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION OF THE INVENTION

### Cytotoxicity of NACA and diNACA in Cystinotic Fibroblast Cell Culture

### Screening of Cystine-Depleting Activity of NACA and diNACA

### Ophthalmic Tolerability of 1% NPI-001, 1% diNACA, 1% NAC or vehicle

### NACA (NPI-001), diNACA (NPI-002), NAC or cysteamine ophthalmic insert.

### Example 5

